CCP slaps Rs150m penalty

LAHORE:

The Competition Commission of Pakistan (CCP) has imposed a penalty of Rs150 million on Reckitt Benckiser Pakistan Limited (respondent) for violation of Section 10 of the Competition Act 2010 in advertising/marketing claims about its product ‘Strepsils’, which have been found capable of misleading and deceiving under the Act. Square Distribution and Marketing System (Pvt) Limited filed a formal complaint, alleging that the company had been disseminating misleading information to consumers by creating impression of its product ‘Strepsils’ as a drug for sore throat and cough. It was alleged that the tablet was de-registered as a drug when acquired by the firm from Boots in 2005, and then re-launched with the disclaimer, “Non-medicated Lozenges.” However, the company made no effort to educate and inform the consumers regarding the discontinuation of medicinal ingredient in it.

Published in The Express Tribune, February 12^th, 2021.

Like Business on Facebook, follow @TribuneBiz on Twitter to stay informed and join in the conversation.